CLINICAL_TRIALS
trial_result
· 2014-07-28
Clinical Trial Update: EASSI - Evaluation of the Safety of Self-Administration With Icatibant [Phase 3]
Summary
Phase 3 trial evaluating the safety of self-administration with icatibant in hereditary angioedema has completed; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2014-07-28